Catalyst Wire Dossier Catalyst Wire Dossier

Tafluprost

tafluprost · Santen Oy
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Tafluprost, covering 2009-09-15 to 2024-04-05. Get the full timeline:

Most recent: FDA Approved: TAFLUPROST — Original Application (Ingenus Pharmaceuticals, LLC)

See pricing